Expanding the clinical indications for α(1)-antitrypsin therapy
about
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsMechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetesToward beta cell replacement for diabetesAging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitorsContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinProteomic differences between male and female anterior cruciate ligament and patellar tendon.Testing agents for prevention or reversal of type 1 diabetes in rodents.RNA-Seq Analysis Reveals Genes Underlying Different Disease Responses to Porcine Circovirus Type 2 in Pigs.Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Effects of open versus laparoscopic nephrectomy techniques on oxidative stress markers in patients with renal cell carcinoma.α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-αAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.Immune-modulating effects of alpha-1 antitrypsin.Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).Host and Environmental Factors Influencing Individual Human Cytokine Responses.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Intra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophilsProphylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice.Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.Characterization of Vitreous and Aqueous Proteome in Humans With Proliferative Diabetic Retinopathy and Its Clinical Correlation.α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation.Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivoRegulation of autophagy by α1-antitrypsin: "a foe of a foe is a friend".Resistin as a Prooxidant Factor and Predictor of Endothelium Damage in Patients with Mild Acute Pancreatitis Exposed to Tobacco Smoke XenobioticsAlpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis.α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes.α-1-antitrypsin inhibits acute liver failure in mice.Traditional and new candidate cardiac biomarkers assessed before, early, and late after half marathon in trained subjects.High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.Identification of Novel Chondroprotective Mediators in Resolving Inflammatory Exudates.Human α1-antitrypsin modifies B-lymphocyte responses during allograft transplantation.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.Revascularization of pancreatic islet allografts is enhanced by α-1-antitrypsin under anti-inflammatory conditions.
P2860
Q26858837-32F1D895-7CE7-4361-B7E2-3DFDA73DAD5EQ26861561-439F86C3-C198-4FBB-BC3F-B74128502F2AQ28083650-3DA11F0C-0BD8-4672-857E-AE0C4EF2718FQ28395194-ED508647-9F44-4866-842C-A7B6121297AEQ28817846-AD1FEA38-E0A3-4A42-B110-D38B4D45F897Q33599524-7D37C23A-792D-4915-A862-6A1B77AAAB36Q34983677-E1648D0B-601E-4B67-A307-255020688C40Q36015404-809D9BA0-72B0-4E7A-BB6A-8C129DC81890Q36126662-7841A93C-70D7-4629-92D2-D853A467C9DEQ36290085-748D0395-5855-413D-BB6B-3ABA67476157Q36682721-C6D6F713-581D-4FDA-884A-802D62BFB58DQ37056456-209C1B16-58F2-4CFB-AFA3-7967867274C2Q37173117-AE307F2C-8BB5-4224-99ED-B7B7CFE04918Q37427900-23152C71-B386-49F9-A14D-5F40C5C1DD9BQ37565386-BE0536B8-F1CC-47EC-B27E-C9DD22141330Q38214040-5291BA7C-31D7-4E26-9646-F9A9FA157A06Q38769762-146E3278-56BE-473E-8130-CEAC33FA8335Q38798523-B174ADAE-4E4A-4293-8163-1834ABAD091EQ38806457-FC59547A-D670-4DBC-847C-9E9DDD1EF2BAQ38875787-B7A1AA7D-DFAA-4748-BBFD-9E22E4003D1CQ38899884-7EA86B0B-BA67-4BDF-9FC4-6433EAC3A080Q38937862-2EF4229B-F387-45E1-B642-FC2EB823CE4CQ39308780-740C6CAC-DA5A-432E-893B-1B41D7720600Q39565971-63266D82-F44E-4D30-B265-99E7EBA5708BQ41507283-948B6DA8-04B2-4235-B861-6338F2444689Q41666547-5DE5B53B-686C-418F-89CE-FF4940CB85FDQ41897708-61C2735D-3372-4FFE-9907-B3BE11EE116BQ42130122-5B5B10E6-11D5-4717-846F-FD31A7B3D916Q42152837-57B92CC5-A17F-47D6-A43F-64FF00DC54ACQ42254495-BBC43CF7-7BD2-448F-81F2-CE5DF12912EFQ42706687-F4DADFA8-C9A1-4A43-8D2A-51310A7C2D7CQ43162026-D3F5B5AC-118F-44D7-A06C-BA21057CC974Q45730015-2E1B095D-F0B8-4739-996B-C4D79236C600Q46902299-F7A81826-A7B9-4EF1-B02C-464B3CA320C9Q47285059-D5AB427C-CA5D-4FD0-9252-CC3A074B3F57Q47747847-C5823EA0-98CE-4EE4-BC12-019AE7FC35FFQ48189143-3E2F1B06-A851-4EA7-8CB1-7B4D759118ABQ50856415-33BA121C-19D1-4BAD-83BD-776CE62EEBC6Q51465416-CF0381C9-1937-4271-970A-67ADE92F8E94Q53140685-671B6296-7CA5-4E33-AB11-02F5F2BE2A5F
P2860
Expanding the clinical indications for α(1)-antitrypsin therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Expanding the clinical indications for α(1)-antitrypsin therapy
@ast
Expanding the clinical indications for α(1)-antitrypsin therapy
@en
Expanding the clinical indications for α(1)-antitrypsin therapy
@nl
type
label
Expanding the clinical indications for α(1)-antitrypsin therapy
@ast
Expanding the clinical indications for α(1)-antitrypsin therapy
@en
Expanding the clinical indications for α(1)-antitrypsin therapy
@nl
prefLabel
Expanding the clinical indications for α(1)-antitrypsin therapy
@ast
Expanding the clinical indications for α(1)-antitrypsin therapy
@en
Expanding the clinical indications for α(1)-antitrypsin therapy
@nl
P2860
P3181
P1433
P1476
Expanding the clinical indications for α(1)-antitrypsin therapy
@en
P2093
P2860
P2888
P304
P3181
P356
10.2119/MOLMED.2011.00196
P407
P577
2012-09-07T00:00:00Z
P5875
P6179
1051429835